We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Leading Cause of Death in Children with Cancer

By HospiMedica staff writers
Posted on 12 Mar 2002
A retrospective study suggests that the greatest direct cause of death in children with cancer admitted to the pediatric intensive care unit (PICU) is multi-organ failure. More...
The study was published in the January 2002 issue of the Journal of Pediatric Hemtology/Oncology.

The researchers, led by Dr. Gideon Paret, of Chaim Sheba Medical Center (Tel Hashomer, Israel), looked at the records of 94 pediatric cancer patients admitted to the PICU from 1989-1999. The overall 30-day survival rate was found to be 66%. Children with respiratory failure showed the highest mortality rate, which was 40%. Children with neurologic deterioration and circulatory collapse also revealed high rates of mortality (31% and 33.3%, respectively).

According to the researchers, the total number of organ system failures was greater among the nonsurvivors. Those children who needed ventilatory or inotropic support had worse outcomes. The mortality rate among children with sepsis was 50%, compared to 24% among children without sepsis. Thirty-six patients (38%) developed sepsis in the PICU, while 17 (18%) were found to have sepsis on admission to the PICU. Sepsis was found to be highly associated with the development of multi-organ failure.

Dr. Paret and his colleagues conclude in the article that "Further refinement of reliable clinical predictors of survival will enable better triage of these children to the PICU for possible prevention of systemic complications and reduction of mortality rates.”




Related Links:
Journal of Pediatric Hematology

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.